Clinical trial
Multi-centre, Open-label Trial to Assess the saFety, Pharmacodynamics, Efficacy and Pharmacokinetics of pegunigaLsidase Alfa in Patients From 2 Years to Less Than 18 Years of Age With Confirmed FabrY Disease
NCT06328608 is registered in ClinicalTrials.gov with Chiesi Farmaceutici S.p.A. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Multi-centre, Open-label Trial to Assess the saFety, Pharmacodynamics, Efficacy and Pharmacokinetics of pegunigaLsidase Alfa in Patients From 2 Years to Less Than 18 Years of Age With Confirmed FabrY Disease
- Lead sponsor
- Chiesi Farmaceutici S.p.A.
- Phase
- Phase 2/3
- Overall status
- Recruiting
- Start date
- July 29, 2025
- Completion date
- April 30, 2031
- Enrollment
- 22 (estimated)
- Sites
- 12
Conditions
As the registry lists them; a condition with its own page is linked.